Liu Jixiang, Duan Shaojie, Wang Yichong, Peng Hongye, Kong Youjia, Yao Shukun
Graduate School of Beijing University of Chinese Medicine, Beijing, China.
Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, China.
Front Med (Lausanne). 2023 Jan 6;9:1077806. doi: 10.3389/fmed.2022.1077806. eCollection 2022.
Superficial non-ampullary duodenal epithelial tumors (SNADETs) as a rare disease have gradually increased in recent years. Underwater endoscopic mucosal resection (UEMR) has emerged as a newly available option for the endoscopic resection of SNADETs. This study aimed to evaluate the efficacy and safety of UEMR for ≤20 mm SNADETs.
A literature search was performed across multiple databases, including PubMed, Embase, Scopus, and Clinical trials for studies containing tumors ≤20 mm published from January 1, 2012, to August 8, 2022. Outcomes examined were the pooled rates of en bloc resection, R0 resection, adverse events, and recurrence. Subgroup analyses of the resection rate were conducted stratified by sample size and polyp size.
A total of 10 studies with UEMR performed in a total of 648 tumors were included for analysis. The pooled rate of en bloc resection and R0 resection was 88.2% (95% confidence interval (CI): 82.1-93.2) and 69.1% (95% CI: 62.2-76.1), respectively. The results showed pooled rate of intraoperative bleeding rate was 2.9% (95% CI: 0-9.0), delayed bleeding rate was 0.9% (95% CI: 0.1-2), recurrence rate was 1.5% (95% CI: 0-4.9). In the subgroup analysis, R0 and en-bloc resection rates were significantly higher in <10 mm than 10-20 mm SNADETs subgroups (R0 resection rate 83.1 vs. 48.6%; en bloc resection rate 100.0 vs. 84.0%, < 0.05).
Underwater endoscopic mucosal resection was an effective and safe technique for the optional treatment for ≤20 mm SNADETs, especially of <10 mm.
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022340578.
浅表性非壶腹十二指肠上皮肿瘤(SNADETs)作为一种罕见疾病,近年来其发病率逐渐上升。水下内镜黏膜切除术(UEMR)已成为内镜切除SNADETs的一种新选择。本研究旨在评估UEMR治疗直径≤20 mm的SNADETs的疗效和安全性。
在多个数据库中进行文献检索,包括PubMed、Embase、Scopus和临床试验数据库,检索2012年1月1日至2022年8月8日发表的包含直径≤20 mm肿瘤的研究。考察的结局指标为整块切除率、R0切除率、不良事件和复发率。根据样本量和息肉大小对切除率进行亚组分析。
共纳入10项关于UEMR治疗648例肿瘤的研究进行分析。整块切除率和R0切除率的合并率分别为88.2%(95%置信区间(CI):82.1 - 93.2)和69.1%(95% CI:62.2 - 76.1)。结果显示术中出血率的合并率为2.9%(95% CI:0 - 9.0),延迟出血率为0.9%(95% CI:0.1 - 2),复发率为1.5%(95% CI:0 - 4.9)。在亚组分析中,直径<10 mm的SNADETs亚组的R0切除率和整块切除率显著高于10 - 20 mm亚组(R0切除率83.1%对48.6%;整块切除率100.0%对84.
水下内镜黏膜切除术是治疗直径≤20 mm,尤其是<10 mm的SNADETs的一种有效且安全的技术。